Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia

MLA

Josep-Maria Ribera. “Efficacy and Safety of Bispecific T-Cell Engager Blinatumomab and the Potential to Improve Leukemia-Free Survival in B-Cell Acute Lymphoblastic Leukemia.” Expert Review of Hematology, vol. 10, Nov. 2017, pp. 1057–67. EBSCOhost, https://doi.org/10.1080/17474086.2017.1396890.

APA

Josep-Maria Ribera. (2017). Efficacy and safety of bispecific T-cell engager blinatumomab and the potential to improve leukemia-free survival in B-cell acute lymphoblastic leukemia. Expert Review of Hematology, 10, 1057–1067. https://doi.org/10.1080/17474086.2017.1396890

Chicago

Josep-Maria Ribera. 2017. “Efficacy and Safety of Bispecific T-Cell Engager Blinatumomab and the Potential to Improve Leukemia-Free Survival in B-Cell Acute Lymphoblastic Leukemia.” Expert Review of Hematology 10 (November): 1057–67. doi:10.1080/17474086.2017.1396890.